These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5231438)

  • 1. A preliminary evaluation of the sedative effects of catapres, a new antihypertensive agent, in chronic schizophrenic patients.
    Simpson GM; Kunz-Bartholini E; Watts TP
    J Clin Pharmacol J New Drugs; 1967; 7(4):221-5. PubMed ID: 5231438
    [No Abstract]   [Full Text] [Related]  

  • 2. Properties of catapres, a new hypotensive drug: a preliminary report.
    Ng J; McGrgor DD; Taylor KM; Smirk H
    N Z Med J; 1967 Dec; 66(425):864-70. PubMed ID: 5236015
    [No Abstract]   [Full Text] [Related]  

  • 3. Clonidine (Catapres): a new antihypertensive agent.
    Khan A; Camel G; Perry HM
    Curr Ther Res Clin Exp; 1970 Jan; 12(1):10-8. PubMed ID: 4984047
    [No Abstract]   [Full Text] [Related]  

  • 4. [Continuous automatic recording of blood pressure after administration of a new antihypertensive substance].
    Haan D
    Arzneimittelforschung; 1966 Sep; 16(9):1180-3. PubMed ID: 6014739
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experience with Catapresan].
    Laux L; Angelmann W
    Med Monatsschr; 1967 Apr; 21(4):186-7. PubMed ID: 5584446
    [No Abstract]   [Full Text] [Related]  

  • 6. Observations on the hypotensive action of "Catapres" (ST 155) in man.
    Barnett AJ; Cantor S
    Med J Aust; 1968 Jan; 1(3):87-91. PubMed ID: 4867515
    [No Abstract]   [Full Text] [Related]  

  • 7. Blind trial with 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155) in essential hypertension. Effects on arterial blood pressures at rest and during exercise and on physical work capacity.
    Koch G
    Arzneimittelforschung; 1970 Dec; 20(12):1857-9. PubMed ID: 5537080
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of severe hypertension with Catapres (St 155). A comparative study of the effect of catapres and methyldopa in a series of hypertensive outpatients (WHO stage 3).
    Becker-Christensen F; Bang HO; Ditzel J
    Acta Med Scand; 1971; 190(1-2):21-6. PubMed ID: 5099124
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of alpha-methyldopa (aldomet) and ST155 (catapres) in the treatment of hypertension.
    Seedat YK; Vawda EI; Mitha S; Ramasar R
    S Afr Med J; 1970 Mar; 44(10):300-1. PubMed ID: 5443298
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on catecholamines, renin and aldosterone following Catapresan (2-(2,6-dichlor-phenylamine)-2-imidazoline hydrochloride) in hypertensive patients.
    Hökfelt B; Hedeland H; Dymling JF
    Eur J Pharmacol; 1970; 10(3):389-97. PubMed ID: 5422465
    [No Abstract]   [Full Text] [Related]  

  • 11. [Administration of a new hypotensive agent 2-(2,6-dichlorphenylamino) imidazoline chlorhydrate in the treatment of essential arterial hypertension].
    Borrello G
    Clin Ter; 1971 Apr; 57(1):9-29. PubMed ID: 5090286
    [No Abstract]   [Full Text] [Related]  

  • 12. [New antihypertensive agent of the imidazoline series: 5-fluoro-methyl-imidazolidinylidene-benzamine-monohydrochloride (flutonidin)].
    Brunner H; Djawan S; Dorda W; Penner E; Grabner G
    Arzneimittelforschung; 1977; 27(8):1599-604. PubMed ID: 334188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hypotensive treatment with an imidazoline derivative].
    Björk-von Bahr S
    Lakartidningen; 1969 Sep; 66(37):3701-4. PubMed ID: 5378942
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical observations on a new antihypertensive drug, 2-(2,6-dichlorphenylamine)-2-imidazoline hydrochloride.
    Smet G; Hoobler SW; Sanbar S; Julis S
    Am Heart J; 1969 Apr; 77(4):473-8. PubMed ID: 5773738
    [No Abstract]   [Full Text] [Related]  

  • 15. [Moxonidine. A new centrally active antihypertensive drug].
    Schrader J; Molderings GJ; Dominiak P
    Internist (Berl); 1992 Oct; 33(10):704-6. PubMed ID: 1428688
    [No Abstract]   [Full Text] [Related]  

  • 16. A pilot study of ST-155 (catapres) in chronic schizophrenics.
    Sugerman AA
    J Clin Pharmacol J New Drugs; 1967; 7(4):226-8. PubMed ID: 5231439
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antihypertensive drug. Dual action lowers blood pressure more effectively].
    MMW Fortschr Med; 2001 May; 143(18):49. PubMed ID: 11387709
    [No Abstract]   [Full Text] [Related]  

  • 18. [Single dose studies on the effect of 2-(2,6-dichlorphenylamino)-2-imidazoline-hydrochloride on blood pressure and pulse in hypertonic subjects and on its tolerance].
    Knobloch H; Moor H
    Arzneimittelforschung; 1966 Sep; 16(9):1169-74. PubMed ID: 6014737
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of clonidine and methyldopa on blood pressure and side effects in hypertensive patients.
    Putzeys MR; Hoobler SW
    Am Heart J; 1972 Apr; 83(4):464-8. PubMed ID: 5041833
    [No Abstract]   [Full Text] [Related]  

  • 20. [Long-term experiences with moxonidine, a new antihypertensive agent].
    Schwarz W; Kandziora J
    Fortschr Med; 1990 Nov; 108(32):616-20. PubMed ID: 2262193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.